Transdermal therapeutic systems (TTS) have become a popular method of drug delivery because they allow drugs to be delivered in a rate-controlled manner, avoiding first-pass metabolism and the fluctuating plasma concentrations encountered with oral medications. Moreover, applying TTS is easy, does not require any assistance as intramuscular or intravenous administration, and provokes fewer side effects than there are with the oral delivery of drugs. Drugs most commonly delivered through TTS are scopolamine, estradiol, nitroglycerin, and clonidine. Unfortunately, TTS may provoke adverse skin reaction as irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD). TTS seems to be ideally suited to produce sensitization because they cause occlusion, irritation, and repeated placement of the allergen at the same skin location. Since TTS consist of an adhesive, an active pharmaceutical drug and enhancing agents, sensitization may develop owing to one of these 3 components. The purpose of this manuscript is to review known responsible allergens of ACD to TTS. We describe also a case report about ACD to TTS caused by rivastigmine in a patient affected by Alzheimer's dementia. Rivastigmine is one of the latest drugs indicated as a known culprit allergen of ACD to TTS.
Reazioni cutanee a cerotti transdermici: Revisione della letteratura e descrizione di un caso da rivastigmina
FOTI, Caterina;BONAMONTE, Domenico
2012-01-01
Abstract
Transdermal therapeutic systems (TTS) have become a popular method of drug delivery because they allow drugs to be delivered in a rate-controlled manner, avoiding first-pass metabolism and the fluctuating plasma concentrations encountered with oral medications. Moreover, applying TTS is easy, does not require any assistance as intramuscular or intravenous administration, and provokes fewer side effects than there are with the oral delivery of drugs. Drugs most commonly delivered through TTS are scopolamine, estradiol, nitroglycerin, and clonidine. Unfortunately, TTS may provoke adverse skin reaction as irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD). TTS seems to be ideally suited to produce sensitization because they cause occlusion, irritation, and repeated placement of the allergen at the same skin location. Since TTS consist of an adhesive, an active pharmaceutical drug and enhancing agents, sensitization may develop owing to one of these 3 components. The purpose of this manuscript is to review known responsible allergens of ACD to TTS. We describe also a case report about ACD to TTS caused by rivastigmine in a patient affected by Alzheimer's dementia. Rivastigmine is one of the latest drugs indicated as a known culprit allergen of ACD to TTS.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
